| Pharma Industry Information |
|||
![]() |
|||
| For the development of New Molecular Entities, global clinical R&D is required: targeted, transparent, standardised and fast track research. Timeline and quality are of central importance. Clinville offers centralised study management and infrastructure. The value of Clinville lies in its total dedication as an e-SMO making the intricacies of performing clinical studies for the pharma-industry more transparent, calculable and controllable. Thus, building a high quality source of investigational sites with up-to-date patient data and permanently ready and motivated to conduct studies for the sponsor pharmaceutical company. Each site participates on average in at least 3 studies per year and is fully familiar with GCP, ICH. Clinville acts as link between pharmaceutical sponsor companies & CROs and physicians with their patient populations, for conducting next level clinical e-trials for pharmaceutical drug development. The following professional services are provided: Feasibility survey - up-to date information on investigators patient capacity per therapeutic area Clinical study services: from patient recruitment only to full study service or full CRO services through affiliation with CRDP Ltd. Study Nurse and Investigator Training Clinville Ltd 27 rue Louis de Savoie 1110 Morges Switzerland - 0041 21 811 00 66 |
|||